Latest filing published 09 Nov 2015 for U.S. Stem Cell, Inc..
Insider track record
No signal scores available.
Closed purchases
Based on 9 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -99.2%Entry US$5.40 · Close at T+365 US$0.05
- -82.7%Entry US$55.00 · Close at T+365 US$9.50
- -58.1%Entry US$42.00 · Close at T+365 US$17.60
- -70.9%Entry US$55.00 · Close at T+365 US$16.00
- -72.3%Entry US$70.00 · Close at T+365 US$19.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Samuel S. Ahn: trading record in brief
Samuel S. Ahn appears in our data through filings on U.S. Stem Cell, Inc. shares, published by SEC (Form 4). The record holds 17 filings, for trades running from 28 March 2011 to 6 November 2015.
Purchases make up the whole of the open-market record (16 purchases, €437k). No amount is published for 6 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2015: 7 purchases and no sales on the market.
Half of the purchases are above €33k and half below. Looking at 9 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -57.9%. They describe history only and say nothing certain about the share price ahead.
The latest filing, published on 9 November 2015, reports an open-market purchase in U.S. Stem Cell, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Samuel S. Ahn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,425 sharesCommon StockSEC:0001185185-15-002831:0Canonical exit: 3 Feb 2016 (T+90)
- 411 sharesCommon StockSEC:0001185185-15-002831:1Canonical exit: 4 Feb 2016 (T+90)
- 2,940 sharesCommon StockSEC:0001185185-15-002805:0Canonical exit: 1 Feb 2016 (T+90)
- 295 sharesCommon StockSEC:0001185185-15-002805:1Canonical exit: 2 Feb 2016 (T+90)
- 2,999,997 sharesCommon StockSEC:0001185185-15-002585:0Canonical exit: 17 Jan 2016 (T+90)
- 2,499,998 sharesCommon StockSEC:0001185185-15-002537:0Canonical exit: 7 Jan 2016 (T+90)
- 2,994,012 shares@ US$0.0067Common StockSEC:0001206774-15-001748:0Canonical exit: 20 Aug 2015 (T+90)
- 5,378,296 shares@ US$0.04Common Stock - Conversion debt to equitySEC:0001145443-14-000898:0
- 2,500,000 shares@ US$0.03Common StockSEC:0001145443-14-000333:0Canonical exit: 8 Oct 2012 (T+90)
- 8,771,929 shares@ US$0.014Common Stock Conversion of debt to equity.SEC:0001145443-14-000333:1Canonical exit: 29 Dec 2013 (T+90)
- 5,500,000 shares@ US$0.02Common StockSEC:0001388431-12-000004:0Canonical exit: 29 Apr 2012 (T+90)
- 1,084,200 shares@ US$0.05Common StockSEC:0001388431-11-000028:0Canonical exit: 29 Feb 2012 (T+90)
- 2,500,000 shares@ US$0.04Common StockSEC:0001388431-11-000027:0Canonical exit: 6 Feb 2012 (T+90)
- 246,480 shares@ US$0.142Common StockSEC:0001388431-11-000008:0Canonical exit: 26 Jun 2011 (T+90)
- 167,790 shares@ US$0.149Common StockSEC:0001388431-11-000008:1Canonical exit: 27 Jun 2011 (T+90)
- 163,400 shares@ US$0.153Common StockSEC:0001388431-11-000008:2Canonical exit: 29 Jun 2011 (T+90)
- 97,400 shares@ US$0.154Common StockSEC:0001388431-11-000008:3Canonical exit: 5 Jul 2011 (T+90)
17 of 17 declarations